The ASH Clinical Practice Guidelines for Acute Myeloid Leukemia (AML) covers the treatment of acute myeloid leukemia in older adults.

Learn more and access the full guidelines: www.hematology.org/AMLguidelines

Learn more about AML at http://www.YouAndAML.com
Dr. David Steensma, an expert on acute myeloid leukemia (AML), explains that doctors do not yet know exactly how to prevent AML. In the future, we may have screening tests for adults. For now, avoiding smoking and tobacco products, or quitting smoking if you smoke, may reduce your risk. Although some AML can develop after treatment for another type of cancer, the benefits of that treatment may outweigh the risk of getting treatment-related AML, or tAML. It is important to talk with your doctor about this.

What might acute myeloid leukemia (AML) patients experience for symptoms, treatment, and coping with AML? AML patient and Empowerment Lead Art Flatau shares the experience of his AML journey from diagnosis, through treatment and AML survival, and advancements in AML treatments. Art also shares his empowerment advice for patients and care partners to ensure optimal care and how he has found a sense of purpose in patient advocacy efforts.

Patient Empowerment Network (PEN) is a 501(c)(3) non-profit organization. PEN’s mission is to fortify cancer patients and care partners with the knowledge and tools to boost their confidence, put them in control of their healthcare journey, and assist them in receiving the best, most personalized care available to ensure they have the best possible outcome. Subscribe now to receive the latest news on cancer treatment and research: https://powerfulpatients.org/connect

Learn more about AML at http://www.YouAndAML.com
Expert Dr. David Steensma explains that secondary acute myeloid leukemia, or secondary AML, is AML that happens in someone who has another condition, such as myelodysplastic syndrome (MDS) or another blood disorder. It can also happen in people who have certain conditions such as Down syndrome. AML-MRC and tAML are two types of secondary AML because they happen in people who already have, or had, another condition.

Learn more about MDS at http://www.YouAndMDS.com
MDS experts, Dr Rafael Bejar and Dr Casey O’Connell, discuss how acute myeloid leukemia (AML) relates to MDS. About 30 percent of people with MDS develop a life-threatening blood cancer called AML. The risk of AML depends on the type of MDS you have and other factors. To help confirm a diagnosis of AML, a bone marrow biopsy is performed to capture all the changes (including genetic) that led to the condition.

#uvahealth #leukemia #bloodcancercauses #bloodcancerawarenessmonth
Acute myeloid leukemia (AML) is a blood cancer that starts in the bone marrow. While chemotherapy is the most common treatment, recent developments have been made targeting specific mutations of the leukemia with alternate therapies, such as oral pills. Oncologist Firas El Chaer, MD, explains the disease and the types of care available at UVA.

Find out more at https://uvahealth.com/services..../blood-cancer/acute-


I'm Firas El Chaer. I focus on acute leukemias and chronic leukemias.

Acute myeloid leukemia is a form of blood cancer that affects the stem cells and our bone marrow.

Acute myeloid leukemia is most commonly treated with chemotherapy. However, over the course of the past few years, we have come to know that these leukemias have a lot of specific mutations, and some of those mutations can be targeted with very specific therapies. Some of those therapies are actually oral pills.

The first step is remission. The second step is, hopefully, a cure. Remission entails that the level of the leukemia cells in their body is at a very low level. In addition, their blood counts should have recovered at a point where they are independent of transfusions. This is what we call remission.

Acute leukemias, particularly acute myeloid leukemia, would be better treated at a large academic center because we have a whole team that can address those patients and their needs. The team usually consists of a pharmacist, a physician, a nurse, a care coordinator, a social worker, and many other members of the team.

Some of those patients will require bone marrow or stem cell transplant. Instead of having to go to another institution, we perform that procedure here.

Another reason why these patients would potentially have more options here at UVA because we have clinical trials addressing acute leukemias.

When patients with acute myeloid leukemia get diagnosed, they feel that this the end of the story. Providing them with that glimpse of hope and showing them that there's light at the end of the tunnel is extremely important.

"Four days later, it was confirmed by a different consultant in Haematology that I had acute myeloid leukaemia (AML). Kevin and I looked at each other and both asked at the same time if it was curable."

Gillian Rackley spent months visiting her GP and even a rheumatologist about her symptoms, but they were put down to a post-viral reaction.

In her story for #SpotLeukaemia, Gillian explains how her symptoms went undiagnosed for so long, and what the future holds for her now.

Learn more about our campaign at www.spotleukaemia.org.uk

Jennifer McNeer, MD, a pediatric hematologist at Comer Children's Hospital at the University of Chicago, shares how advanced diagnostic techniques help physicians to better characterize and treat each child's case of acute myeloid leukemia (AML). Learn more about the symptoms, diagnosis, and treatment options for childhood acute myeloid leukemia.
 Learn more At Forefront of Medicine:
Website: http://www.uchicagomedicine.org
Twitter: http://www.twitter.com/uchicagomed
Facebook: http://www.facebook.com/uchicagomed
Make an appointment today at 888-824-0200.